Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.08.2023 | Case report

Diflunisal

Reduction in creatinine clearance and gastrointestinal bleeding: 8 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Siddiqi OK, et al. Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience. Amyloid - Journal of Protein Folding Disorders 29: 71-78, No. 2, 2022. Available from: URL: http://doi.org/10.1080/13506129.2021.2000388 Siddiqi OK, et al. Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience. Amyloid - Journal of Protein Folding Disorders 29: 71-78, No. 2, 2022. Available from: URL: http://​doi.​org/​10.​1080/​13506129.​2021.​2000388
Metadaten
Titel
Diflunisal
Reduction in creatinine clearance and gastrointestinal bleeding: 8 case reports
Publikationsdatum
01.08.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45230-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs